GE joins crowd with baby cyclotron

Article

Scanditronix was omitted in our last issue from a list of vendors(SCAN 7/31/91) that have developed negative-ion cyclotrons--so-calledbaby cyclotrons--for the production of positron emission tomographyradiopharmaceuticals. Negative-ion machines don't

Scanditronix was omitted in our last issue from a list of vendors(SCAN 7/31/91) that have developed negative-ion cyclotrons--so-calledbaby cyclotrons--for the production of positron emission tomographyradiopharmaceuticals.

Negative-ion machines don't produce the radiation that traditionalPET cyclotrons generate, so shielding requirements are reduced.The lower shielding requirement trims manufacturing and sitingcosts, which in turn reduces the overall cost of operating a PETsystem (see story, page one).

GE Medical Systems, which purchased the Scanditronix PET camerabusiness early last year (SCAN 12/13/89), is exclusive distributorof the PETtrace 200 cyclotron, said Dow R. Wilson, GE PET marketingmanager.

With GE marketing the Scanditronix negative-ion system, allthree major PET vendors--Siemens, Positron and GE--now offer thelower cost technology.

The PETtrace 200 is a dual-particle cyclotron. The advantageof this technology is that two targets can be irradiated at once,producing two different isotopes simultaneously, Wilson said.

"This is beneficial if you have a big program or multiplescanners that you are supporting," he said.

The Scanditronix cyclotron can produce oxygen-15, nitrogen-13,carbon-11 and fluorine-18 PET tracers.

GE's relationship with Scanditronix works well for both sides,Wilson said. The world's largest medical imaging equipment vendorhas no desire to build cyclotrons.

"We want to stick to our knitting," he said. "Weare an image processing and sales and service company. We don'twant to be an accelerator manufacturer. Scanditronix is as goodat that as anyone--maybe better. We want them to stick to theirknitting, so they can engineer and manufacture a state-of-the-artcyclotron, and we can market it for them."

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.